Please login to the form below

Not currently logged in
Email:
Password:

generics

This page shows the latest generics news and features for those working in and with pharma, biotech and healthcare.

China approves Ironwood Pharma’s IBS treatment

China approves Ironwood Pharma’s IBS treatment

Mark Mallon, CEO, Ironwood Pharmaceuticals and Cyclerion. Ironwood and Allergan (its US marketing partner) have also just secured a vital Linzess patent settlement with generic challenger Mylan.

Latest news

More from news
Approximately 76 fully matching, plus 1,677 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    radioligands and CAR‐T for cancer. $2.1B. Sale. Aurobindo. NovartIs sold part of Sandoz’s US generics. ... branded and generic competitors by being active in both sides of the market.

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    These new products will help offset the patent expiry of one of Pfizer’s biggest products, pain treatment Lyrica, which will see generics arrive at the end of December. ... generic medicines.

  • The race for a HIV ‘cure’ The race for a HIV ‘cure’

    Most of our medicines in Europe are available at the same time, at generic prices, in Africa – in hepatitis C, the drugs are available earlier in Africa than Europe because of ... As soon as we know how to manufacture our pills, we hand it over to the

  • Happy 70th birthday NHS: the next 70 need to be very different Happy 70th birthday NHS: the next 70 need to be very different

    It also seems to be relatively efficient, with low admin costs and high use of cheaper generic medicines, and also performs well in managing long-term illnesses, such as diabetes.

  • The rise of vertical integration in the US payer landscape The rise of vertical integration in the US payer landscape

    They may focus primarily on lowering total cost of care and maximising low net cost drug utilisation (eg, generics) rather than driving rebate and owned-channel volume.

More from intelligence
Approximately 6 fully matching, plus 153 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 31 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 51 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics